United States · Who invested in Interius BioTherapeutics?
Interius BioTherapeutics's investors include RA Capital Management, Cormorant Asset Management, Longwood Fund and Bain Capital Life Sciences.
2025
$51MSeries B$22MVenture
United States · Venture startup
Who invested in Interius BioTherapeutics
Funding summaryUpdated 26 Oct 2026
$73Mraised across 2 rounds since 2024, from 2 sources
$51MSeries B$22MVenture
- Latest round
- Venture, $22MJan 2025
- Biggest round
- $51MSeries B · Jun 2024
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $51M Jun 2024
- Biggest round
- $51M Series B · Jun 2024
- Between rounds
- 7 months from the last two
The rounds
- Jan 2025Venture$22M1 new3 returning
Source recorded
- Jun 2024Series B$51M3 new
Source recordedSEC filing: $51M sold, first sale May 2024
Founders and team
From the SEC filings it signed: 2 on the team.
- Dora R. MitchellExecutive Officeri
- Philip R. JohnsonExecutive Officer, Directori
On the board, as filediBihua O. ChenLeon R. MoulderTomas R. Kiselak
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series B2024Venture2025
RA Capital Management
Cormorant Asset Management
Longwood FundBain Capital Life Sciences
RA Capital ManagementCormorant Asset ManagementLongwood FundBain Capital Life SciencesEveryone who backed them
Bain Capital Life SciencesPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Interius BioTherapeutics
How much has Interius BioTherapeutics raised?
Interius BioTherapeutics has raised $73M across 2 rounds since 2024.
When did Interius BioTherapeutics last raise?
Interius BioTherapeutics's most recent round was a Venture of $22M in Jan 2025.
What was Interius BioTherapeutics's biggest round?
Interius BioTherapeutics's largest round on record is $51M (Series B), in Jun 2024.
Who backed Interius BioTherapeutics first?
Interius BioTherapeutics's first round on record, in Jun 2024, was backed by RA Capital Management, Cormorant Asset Management and Longwood Fund.
What stage is Interius BioTherapeutics at?
Interius BioTherapeutics's latest named round is a Venture, in Jan 2025.
Where is Interius BioTherapeutics based?
Interius BioTherapeutics is based in the United States.
Companies like Interius BioTherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.